000162614 001__ 162614
000162614 005__ 20251017144551.0
000162614 0247_ $$2doi$$a10.1177/0883073811405055
000162614 0248_ $$2sideral$$a74666
000162614 037__ $$aART-2011-74666
000162614 041__ $$aeng
000162614 100__ $$aMacIpe-Costa,R.
000162614 245__ $$aDifferences in methylphenidate use between immigrants and spaniards in the child population of Aragon, Spain: A retrospective study
000162614 260__ $$c2011
000162614 5060_ $$aAccess copy available to the general public$$fUnrestricted
000162614 5203_ $$aThe aim of this research is to study the differences in methylphenidate use in children from different ethnic groups in the region of Aragon, Spain. Differences in the use of methylphenidate between both groups of children, immigrants and Spanish nationals, were assessed based on the total number of methylphenidate prescriptions made out for all children in Aragon in 2008 (N = 98 837). We have used defined daily doses and the defined daily doses per 1000 inhabitants per day. Defined daily doses per 1000 inhabitants per day of methylphenidate use was 18.49 in Spanish boys compared with 2.70 in immigrant boys, and 5.48 in Spanish girls versus 0.83 in immigrant girls. All differences between groups were statistically significant (P < .001). This study confirms that methylphenidate use is higher in a local population than in an immigrant population. Western European and North American children show the highest use, followed by Latin Americans and Eastern Europeans.
000162614 536__ $$9iinfo:eu-repo/grantAgreement/ES/ISCIII-RedIAPP/RD06-018
000162614 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000162614 590__ $$a1.748$$b2011
000162614 591__ $$aPEDIATRICS$$b43 / 115 = 0.374$$c2011$$dQ2$$eT2
000162614 591__ $$aCLINICAL NEUROLOGY$$b117 / 192 = 0.609$$c2011$$dQ3$$eT2
000162614 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion
000162614 700__ $$0(orcid)0000-0002-3797-4218$$aGarcía-Campayo,J.$$uUniversidad de Zaragoza
000162614 700__ $$0(orcid)0000-0003-2928-6623$$aGimeno-Feliu,L.$$uUniversidad de Zaragoza
000162614 700__ $$0(orcid)0000-0002-5494-6550$$aMagallón-Botaya,R.$$uUniversidad de Zaragoza
000162614 700__ $$aArmesto-Gomez,J.$$uUniversidad de Zaragoza
000162614 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000162614 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia
000162614 7102_ $$11007$$2745$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Psiquiatría
000162614 773__ $$g26, 10 (2011)$$pJ. child neurol.$$tJOURNAL OF CHILD NEUROLOGY$$x0883-0738
000162614 8564_ $$s490056$$uhttps://zaguan.unizar.es/record/162614/files/texto_completo.pdf$$yPostprint
000162614 8564_ $$s1010470$$uhttps://zaguan.unizar.es/record/162614/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000162614 909CO $$ooai:zaguan.unizar.es:162614$$particulos$$pdriver
000162614 951__ $$a2025-10-17-14:11:59
000162614 980__ $$aARTICLE